Goldenwell Biotech Stock Net Income
| GWLL Stock | USD 1.05 0.00 0.00% |
As of the 13th of February 2026, Goldenwell Biotech retains the Risk Adjusted Performance of (0.06), standard deviation of 7.75, and Market Risk Adjusted Performance of 0.6521. Goldenwell Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Goldenwell Biotech standard deviation and value at risk to decide if Goldenwell Biotech is priced fairly, providing market reflects its last-minute price of 1.05 per share. Given that Goldenwell Biotech is a hitting penny stock territory we urge to closely look at its jensen alpha.
Goldenwell Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Goldenwell Biotech's valuation are provided below:Goldenwell Biotech does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Goldenwell |
Goldenwell Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Goldenwell Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Goldenwell Biotech.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Goldenwell Biotech on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Goldenwell Biotech or generate 0.0% return on investment in Goldenwell Biotech over 90 days. Goldenwell Biotech is related to or competes with Grupo KUO, RCL Foods, Zinzino AB, Ausnutria Dairy, Select Harvests, Perusahaan Perkebunan, and Origin Enterprises. Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States More
Goldenwell Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Goldenwell Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Goldenwell Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (12.23) |
Goldenwell Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Goldenwell Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Goldenwell Biotech's standard deviation. In reality, there are many statistical measures that can use Goldenwell Biotech historical prices to predict the future Goldenwell Biotech's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.39) | |||
| Treynor Ratio | 0.6421 |
Goldenwell Biotech February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.6521 | |||
| Mean Deviation | 2.7 | |||
| Coefficient Of Variation | (1,099) | |||
| Standard Deviation | 7.75 | |||
| Variance | 60.05 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.39) | |||
| Treynor Ratio | 0.6421 | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (12.23) | |||
| Skewness | 3.37 | |||
| Kurtosis | 28.53 |
Goldenwell Biotech Backtested Returns
Goldenwell Biotech holds Efficiency (Sharpe) Ratio of -0.33, which attests that the entity had a -0.33 % return per unit of risk over the last 3 months. Goldenwell Biotech exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Goldenwell Biotech's Standard Deviation of 7.75, risk adjusted performance of (0.06), and Market Risk Adjusted Performance of 0.6521 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -1.11, which attests to a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Goldenwell Biotech are expected to decrease slowly. On the other hand, during market turmoil, Goldenwell Biotech is expected to outperform it slightly. At this point, Goldenwell Biotech has a negative expected return of -1.58%. Please make sure to check out Goldenwell Biotech's standard deviation, value at risk, as well as the relationship between the Value At Risk and day typical price , to decide if Goldenwell Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.54 |
Modest predictability
Goldenwell Biotech has modest predictability. Overlapping area represents the amount of predictability between Goldenwell Biotech time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Goldenwell Biotech price movement. The serial correlation of 0.54 indicates that about 54.0% of current Goldenwell Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.6 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Goldenwell Biotech reported net income of (107,480). This is 100.01% lower than that of the Consumer Defensive sector and 99.89% lower than that of the Packaged Foods industry. The net income for all United States stocks is 100.02% higher than that of the company.
Goldenwell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Goldenwell Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Goldenwell Biotech could also be used in its relative valuation, which is a method of valuing Goldenwell Biotech by comparing valuation metrics of similar companies.Goldenwell Biotech is currently under evaluation in net income category among its peers.
Goldenwell Fundamentals
| Return On Equity | -36.4 | |||
| Return On Asset | -17.19 | |||
| Operating Margin | (568.00) % | |||
| Current Valuation | 28.31 M | |||
| Shares Outstanding | 96 M | |||
| Shares Owned By Insiders | 62.50 % | |||
| Price To Book | 98.33 X | |||
| Revenue | 18.97 K | |||
| Gross Profit | 8.39 K | |||
| Net Income | (107.48 K) | |||
| Cash And Equivalents | 42.86 K | |||
| Total Debt | 32.87 K | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 7.29 X | |||
| Cash Flow From Operations | (202.57 K) | |||
| Market Capitalization | 28.32 M |
About Goldenwell Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Goldenwell Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goldenwell Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goldenwell Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.